Document is current
Any future updates will be listed below
-
Authors
Berg, Lisa M.
Gurr, Caroline
Leyhausen, Johanna
Seelemeyer, Hanna
Bletsch, Anke
Schaefer, Tim
Pretzsch, Charlotte M.
Oakley, Bethany
Loth, Eva
Floris, Dorothea L.
Buitelaar, Jan K.
Beckmann, Christian F.
Banaschewski, Tobias
Charman, Tony
Jones, Emily J. H.
Tillmann, Julian
Chatham, Chris H.
Bourgeron, Thomas
,
Ahmad, Jumana
Ambrosino, Sara
Auyeung, Bonnie
Baron-Cohen, Simon
Baumeister, Sarah
Bölte, Sven
Bours, Carsten
Brammer, Michael
Brandeis, Daniel
Brogna, Claudia
de Bruijn, Yvette
Chakrabarti, Bhismadev
Cornelissen, Ineke
Crawley, Daisy
Dell’Acqua, Flavio
Dumas, Guillaume
Durston, Sarah
Faulkner, Jessica
Frouin, Vincent
Garcés, Pilar
Goyard, David
Ham, Lindsay
Hayward, Hannah
Hipp, Joerg
Holt, Rosemary
Johnson, Mark H.
Kundu, Prantik
Lai, Meng-Chuan
D’Ardhuy, Xavier Liogier
Lombardo, Michael V.
Lythgoe, David J.
Mandl, René
Marquand, Andre
Mason, Luke
Mennes, Maarten
Meyer-Lindenberg, Andreas
Moessnang, Carolin
Bast, Nico
O’Dwyer, Laurence
Oldehinkel, Marianne
Oranje, Bob
Pandina, Gahan
Persico, Antonio M.
Ruggeri, Barbara
Ruigrok, Amber
Sabet, Jessica
Sacco, Roberto
Cáceres, Antonia San José
Simonoff, Emily
Spooren, Will
Toro, Roberto
Tost, Heike
Waldman, Jack
Williams, Steve C. R.
Wooldridge, Caroline
Zwiers, Marcel P.
Murphy, Declan G.
Ecker, Christine
-
Funding
Funding for this research was provided by:
European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie (No 101025785)
the Innovative Medicines Initiative 2 Joint Undertaking (No 115300 & No 777394)
NIHR Maudsley Biomedical Research Centre
German Research Foundation (DFG) under the Heisenberg Programme (EC480/1-1 and EC480/2-1)
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 13 June 2023
Accepted: 19 September 2023
First Online: 4 October 2023
Declarations
:
: An independent ethics committee at each site approved the study, and written informed consent was obtained for all participants.
: The IMI-JU2 had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. Any views expressed are those of the author(s) and not necessarily those of the IMI-JU2. Jan K. Buitelaar has been in the past 3 years a consultant to/member of advisory board of/and/or speaker for Janssen Cilag BV, Takeda/Shire, Roche, Novartis, Medice, Angelini, and Servier. He is not an employee of any of these companies and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, and royalties. Tobias Banaschewski has served in an advisory or consultancy role for Actelion, Hexal Pharma, Lilly, Medice, Novartis, Oxford outcomes, Otsuka, PCM scientific, Shire and Viforpharma. He received conference support or speaker’s fee by Medice, Novartis and Shire. He is/has been involved in clinical trials conducted by Shire and Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press. The present work is unrelated to the above grants and relationships. Julian Tillmann is a consultant for F. Hoffmann-La Roche Ltd. Chris H. Chatham is an employee of F. Hoffmann–La Roche. Tony Charman has received research grant support from the Medical Research Council (UK), the National Institute for Health Research, Horizon 2020 and the Innovative Medicines Initiative (European Commission), MQ, Autistica, FP7 (European Commission), the Charles Hawkins Fund, and the Waterloo Foundation. He has served as a consultant to F. Hoffmann-La Roche Ltd and Servier. He has received royalties from Sage Publications and Guilford Publications. Declan G. Murphy has received consultancy fees from Roche and Servier, and grant support from the Medical Research Council (UK), the National Institute for Health Research, Horizon 2020 and the Innovative Medicines Initiative (European Commission). Lisa M. Berg, Tim Schaefer, Caroline Gurr, Johanna Leyhausen, Hanna Seelemeyer, Charlotte M. Pretzsch, Bethany Oakley, Eva Loth, Dorothea L. Floris, Christian F. Beckmann, Emily J.H. Jones, Thomas Bourgeron, and Christine Ecker reported no biomedical financial interests or potential conflicts of interest.
